ADVISORY RESEARCH INC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 204 filers reported holding BEAM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.

Quarter-by-quarter ownership
ADVISORY RESEARCH INC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$449,000
-70.6%
7,842
-59.1%
0.04%
-70.0%
Q4 2021$1,529,000
-42.5%
19,192
-37.2%
0.12%
-29.8%
Q3 2021$2,658,000
-24.7%
30,543
+11.4%
0.17%
-26.3%
Q2 2021$3,528,000
+117.0%
27,408
+35.0%
0.23%
+101.7%
Q1 2021$1,626,000
+201.7%
20,309
+207.8%
0.12%
+187.5%
Q4 2020$539,0006,5990.04%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$205,573,00024.93%
HSG Holding Ltd 796,089$69,268,0006.22%
DC Investments Management, LLC 21,010$1,828,0003.41%
Redmile Group, LLC 1,975,006$171,845,0003.00%
Casdin Capital, LLC 818,820$71,246,0001.77%
Evolutionary Tree Capital Management, LLC 44,390$3,862,0001.71%
HHLR ADVISORS, LTD. 1,448,161$126,004,0001.65%
Nan Fung Group Holdings Ltd 54,903$4,777,0001.53%
ARK Investment Management 6,841,722$595,298,0001.43%
BRANDYWINE MANAGERS, LLC 12,900$1,122,0001.17%
View complete list of BEAM THERAPEUTICS INC shareholders